deltatrials
Completed PHASE3 NCT00000432

Lyme Disease Prevention Program

A Controlled Trial of a Primary and Secondary Program for Lyme Disease

Sponsor: Brigham and Women's Hospital

Conditions Lyme Disease Tick-Borne Diseases
Interventions Education about disease prevention
Updated 5 times since 2017 Last updated: Dec 23, 2013 Started: Apr 30, 1997 Primary completion: Mar 31, 2001 Completion: Mar 31, 2001

This PHASE3 trial investigates Lyme Disease and Tick-Borne Diseases and is currently completed. Brigham and Women's Hospital leads this study, which shows 5 recorded versions since 1997 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Apr 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Brigham and Women's Hospital
  • Centers for Disease Control and Prevention
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Hyannis, United States